In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control - Pistrosch, F; Passauer, J; Fischer, S; Fuecker, K; Hanefeld, M; Gross, P (Diabetes Care, 2004)